Cirugía Robótica de Cadera & Rodilla, Dr. Victor Ortiz. Sistema de cirugía asistida por brazo robótico Mako. asistida por brazo robótico Mako. El sistema de cirugía asistida por brazo robótico Mako, proporciona una experiencia quirúrgica más predecible en los reemplazos articulares, ofrece aplicaciones para reemplazo parcial y total de rodilla, y reemplazo total de cadera. La segmentación de los datos de la tomografía computarizada (TC) genera un modelo de la anatomía ósea del paciente en 3D que permite una planificación preoperatoria específica para cada persona. El plan individualizado es revisado por el médico antes del procedimiento y el brazo robótico realiza la preparación ósea para lograr un posicionamiento preciso y funcional del implante. El sistema ayuda al cirujano a realizar ajustes intraoperatorios para optimizar la colocación del implante. Los datos cinemáticos y de los tejidos blandos son recolectados intraoperatoriamente y aplicados al modelo de TC virtual, y basándose en ellos el médico puede revisar de nuevo el plan preoperatorio y, si es necesario, modificarlo para para obtener un balance dinámico de la articulación. Minimally Invasive MAKO Robotic-Assisted Outpatient Hip & Knee Joint Replacement Surgery performed by Robert A. Kayal, M.D., our Chief of Orthopaedic Surgery. #Mako Smart-Robotics is an innovative solution for many suffering from painful arthritis of the knee or hip. Mako uses a 3D CT-based planning software so your surgeon can know more about your anatomy to create a personalized joint replacement surgical plan. When you are experiencing pain or other problems with your #Hip, you don’t need to travel for the best care possible! Take the next step - contact us today 844-777-0910 201-861-4447 www.kayalortho.com Necesitas un Cirujano especializado en ORTOPEDIA , cirugia robotica o Quiropráctico. Llamanos para una consulta. Hablamos ESPAÑOL. Para obtener más información sobre cómo un especialista en ortopedia puede ayudarlo a usted o a un ser querido, contáctenos: 844-777-0910 201-861-4447 www.KayalOrtho.com

Anxiety Anxiety is a normal reaction to stress and can be beneficial in some situations. It can alert us to dangers and help us prepare and pay attention. Anxiety disorders differ from normal feelings of nervousness or anxiousness and involve excessive fear or anxiety. Anxiety disorders are the most common of mental disorders and affect more than 25 million Americans. But anxiety disorders are treatable and a number of effective treatments are available. Treatment helps most people lead normal productive lives.

A major depressive disorder is a serious medical illness affecting an estimated 18 million American adults. CDC estimates that 8.1 percent of American adults ages 20 and over had depression in any given 2-week period from 2013 to 2016. One in eight middle-aged women in the United States has depression, a new report finds. This means that women ages 40 to 59 have the highest rate of depression (12.3 percent) of any group based on age and gender in the U.S., according to the report from the Centers for Disease Control and Prevention. Among Americans ages 12 and older, 9.5 percent of females and 5.6 percent of males had moderate or severe depression Abuse. Past physical, sexual, or emotional abuse can cause depression later in life. The focus of Individual Therapy efforts center on areas of individuals’ lives that they have a concern. These areas commonly involve conditions that are causing a great deal of distress in the individual’s life. Individual therapy has proven fundamental in treating depression.

A medida que se siguen desarrollando noticias sobre la propagación y la gravedad de COVID-19, nuestra primera prioridad es ayudar a mantener seguros a los pacientes con cáncer de VEJIGA, PROSTATA O RIÑON, sobrevivientes, cuidadores y sus seres queridos. Hoy estamos haciendo esta video para apoyar a la comunidad durante este momento alarmante, y todo se reduce a esto: no estás solo. Para ayudarlo a usted y a sus seres queridos, hemos reunido recursos para conectarlo con el apoyo de la comunidad, responder preguntas frecuentes específicas sobre el cáncer de VEJIGA, PROSTATA O RIÑON y COVID-19, y para ayudarlo a encontrar asistencia directa si la necesita. Y mucho mas importante es comunicarlo en nuestro idioma y de esta manera tener mas claridad, entendimiento y que las recomendaciones sean o puedan ser entendidas mas directas. La nueva enfermedad respiratoria comúnmente conocida como "coronavirus" y oficialmente llamada COVID-19 ha cambiado la vida tal como la conocemos en el futuro previsible. Puede ser alarmante escuchar informes de noticias sobre la propagación del coronavirus, el cierre de ciudades y expertos que nos dicen que nos quedemos en casa y limitemos el contacto con otros. Adaptarse a esta nueva normalidad donde las escuelas y las empresas están cerradas puede ser difícil, y muchos están preocupados por cómo se verán afectados sus trabajos y finanzas. Para las personas con problemas de salud graves, como el cáncer de VEJIGA, PROSTATA O RIÑON y sus seres queridos, la incertidumbre de esta situación, la necesidad de distanciamiento físico y las posibles demoras en los tratamientos contra el cáncer pueden ser especialmente angustiantes. Es muy importante saber que las personas que reciben tratamiento para el cáncer de seno pueden tener un mayor riesgo de enfermedad grave si se infectan con este coronavirus. Algunos tratamientos para el cáncer de VEJIGA, PROSTATA O RIÑON, que incluyen quimioterapia, terapias dirigidas, inmunoterapia y radiación, pueden debilitar el sistema inmunitario y posiblemente causar problemas pulmonares. Las personas que tienen sistemas inmunes debilitados o problemas pulmonares tienen un riesgo mucho mayor de complicaciones si se infectan con este virus. Las personas con cáncer de VEJIGA, PROSTATA O RIÑON que ha hecho metástasis (diseminación) a los pulmones también pueden tener problemas pulmonares que pueden empeorar si desarrollan COVID-19. Además, muchos hospitales y proveedores de atención médica están retrasando las cirugías "electivas", los exámenes de detección y otros procedimientos, que se consideran no urgentes o que no ponen en peligro la vida de inmediato. Estas decisiones difíciles se toman caso por caso para proteger a las personas con cáncer de la infección y para asegurarse de que los proveedores de atención médica tengan los recursos que necesitan para tratar a las personas que se enferman gravemente de COVID-19. El Centro para el Control y la Prevención de Enfermedades (CDC) dicen que el riesgo actual de infectarse con este coronavirus sigue siendo bajo para la mayoría de las personas aquí en los Estados Unidos. Pero el CDC esperan que el virus se propague aún más en los próximos meses, por lo que es importante escuchar a los expertos en salud que recomiendan quedarse en casa, limitar el contacto con otras personas y seguir otras precauciones. #cancer #cancerDeProstata #teaneckNJ #HolyNameHospital #DrParra #westnewyorknj #MDTVNews

Prostate Cancer and Current Diagnostic Tools, Dr. Parra In American men, prostate cancer is only behind skin cancer as the most common form of cancer. Statistics showed in the U.S. there were about 164,690 new diagnoses of prostate cancer and about 29,430 death from prostate cancer in 2018. In their lifetime 1-9 men will be diagnosed with prostate cancer, and 1 in 41 of those diagnosed will succumb to complications related to the disease. The five-year survival rate for prostate cancer patients falls to 29% when prostate cancer metastasizes and spreads through the body. This staggering decline in survival rate highlights the serious disadvantages the NCCN recommended treatments have when trying to treat prostate cancer that has spread, become treatment-resistant, and recurrent. PROSTATE IMAGING: a new horizon in early prostate cancer detection and treatment Recent advances in MRI, including Mp-MRI (“Multi-parametric” testing using a 3T scanner)imaging, have changed everything. The latest generation of MRI machines called 3 Tesla, or 3T machines, scan at a much higher resolution than the earlier machines. They enable radiologists to see all but the tiniest tumors. The tumors that they can’t see almost certainly don’t matter. MRI scanning for prostate cancer could also help a quarter of a million men, maybe up to half a million men a year, to avoid an unnecessary biopsy if the MRI is negative. Scanning the prostate in men with PSA elevation is a brand new approach that is more reliable than the old-fashioned method of using 12 random needle sticks. However, this claim is only accurate when using the very latest state-of-the-art MRI technology at approved centers. This technology is so new that finding doctors willing to abandon the old random needle biopsy approach is still a major challenge.  The majority of men will be reassured they don’t have prostate cancer and importantly they may be able to avoid the harms of a biopsy, plus healthcare systems will be able to avoid the costs. MRI is the perfect tool because it’s relatively cheap, widely available and reliable Raul Parra, MD Director of Urologic Oncology Specializes in: - Oncology - Surgical Oncology - Urologic Oncology - Urology Office Location: 718 Teaneck Road Teaneck, NJ 07666 Phone: 201-541-5960 Fax: 201-541-5988 Website: www.holyname.org/westnewyork Raul O. Parra, MD, is a board-certified urologic oncologist specializing in cancers of the bladder, kidney, and prostate. Dr. Parra, who came to Holy Name Medical Partners from Memorial Sloan Kettering Cancer Center, is one of the pioneers of minimally invasive surgery for urologic malignancies and performed the first laparoscopic removal for bladder cancer. He has been at the forefront of innovative laparoscopic and robotic procedures for prostate and kidney cancer used throughout the world today. Dr. Parra has been named a Top Doctor by Castle Connolly. At Holy Name, he is the Director of Urologic Oncology, as well as Medical Director of the Regional Cancer Center. He oversees the Center's comprehensive diagnostic, treatment and support services, including medical and radiation oncology, as well as clinical research trials. In practice for more than 30 years, Dr. Parra was on staff at Memorial Sloan Kettering from 2008 until 2015, when he joined Holy Name. Prior to that, he was Chief of Urology at both St. Louis University Medical Center and Mayo Clinic–Jacksonville, Director of Urologic Oncology at Oregon Health and Science University, and Chief of Urology at Cooper University Hospital/University of Medicine and Dentistry of New Jersey. He also held academic appointments as Professor of Urology at Weill Cornell Medical Center, Memorial Sloan Kettering, Saint Louis University,

In American men, prostate cancer is only behind skin cancer as the most common form of cancer. Statistics showed in the U.S. there were about 164,690 new diagnoses of prostate cancer and about 29,430 death from prostate cancer in 2018. In their lifetime 1-9 men will be diagnosed with prostate cancer, and 1 in 41 of those diagnosed will succumb to complications related to the disease. The five-year survival rate for prostate cancer patients falls to 29% when prostate cancer metastasizes and spreads through the body. This staggering decline in survival rate highlights the serious disadvantages the NCCN recommended treatments have when trying to treat prostate cancer that has spread, become treatment-resistant, and recurrent. Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. PROSTATE IMAGING: a new horizon in early prostate cancer detection and treatment Recent advances in MRI, including Mp-MRI (“Multi-parametric” testing using a 3T scanner)imaging, have changed everything. The latest generation of MRI machines called 3 Tesla, or 3T machines, scan at a much higher resolution than the earlier machines. They enable radiologists to see all but the tiniest tumors. The tumors that they can’t see almost certainly don’t matter. MRI scanning for prostate cancer could also help a quarter of a million men, maybe up to half a million men a year, to avoid an unnecessary biopsy if the MRI is negative.

Beware of the Domino Effect!!! Any form of discipline on your record can create a domino effect that has an impact on which insurers you can participate with, your hospital privileges, and licensure in other states. If you’ve been disciplined in one state, you must report it to all other states you’re licensed in. If you don’t, you can lose your license in those states.

HOW COMMON ARE DISCIPLINARY ACTIONS AGAINST DOCTORS ?‬‪“NJ Board of Medical Examiners receives around 1000 complaints per year”‬The Power of Licensing BoardsThe “thorn on the side” driving the ire of most doctors is, of course, malpractice lawsuits. A civil action, based on allegations only, brought by an attorney on behalf of a private party in a court of law, seeking monetary damages from that doctor’s insurer, is the most common scenario conjured up when one thinks of “malpractice”. These lawsuits are now so common that special judges are often assigned exclusively to their adjudication.

How States Regulate Their Doctors — and Why Doctors Should Take Note. As most doctors consider their practice and skills to be beyond reproach, they will rarely consider that they may need to understand exactly how and why their state’s licensing body doles out punishment to fellow members of their profession. Licensing Board discipline is just not a subject that is taught in Medical School, but doctors investigated and disciplined by those boards often wish they had acquired such knowledge before their practice came under the harsh light of scrutiny. The Power of Licensing Boards The “thorn on the side” driving the ire of most doctors is, of course, malpractice lawsuits. A civil action, based on allegations only, brought by an attorney on behalf of a private party in a court of law, seeking monetary damages from that doctor’s insurer, is the most common scenario conjured up when one thinks of “malpractice”. These lawsuits are now so common that special judges are often assigned exclusively to their adjudication. The issue of tort reform and the ever-increasing vigilance associated with risk management is familiar to every health care practitioner in the United States today. Many outside of the medical profession, not familiar with health regulations, still believe that the primary penalties for “bad doctors” is a negative verdict or whopping settlement stemming from these actions. However, medical practitioners who have undergone the crucible of a medical board action will quickly advise you that there is nothing as stressful and upending as a disciplinary action by a state medical board. Note that a medical malpractice lawsuit is handled by an insurer and their assigned attorney; a doctor need not expend his own money for either lawyer’s fees or ultimate settlement of the claim. In addition, most health professionals understand that the mere fact that a doctor has been named in a lawsuit for malpractice may have nothing whatsoever to do with any wrongdoing on his or her part.  #HealthCareLaw #AlexKeoskey #medicalcomplaint #medicaldisciplinaryaction #medicallicensesuspension #NJ #njlaw #Lawyers #Physicians #njphysicians #medicalboard #healthlawyer #medical #BreastCancer #LungCancer #cll #ProstateCancer #obesity #hypertension #strokes #OvarianCancer  #pancreaticCancer #breastcancerawareness  #digitaltv #ny #bestmedicalnews #dermatolgy #oncology #painmedicine #spinesurgery #orthopedics #medicine  #mddigitastv #mdtvonline #mdtvnews #oncology For more information visit: www.mddigitastv.com https://mddigitastv.com/how-states-regulate-their-doctors-and-why-doctors-should-take-note/ Alex J. Keoskey, Esq. Certified by the N.J. Supreme Court as a Civil Trial Attorney Certified by AAPC as a Professional Health Compliance Officer Decotiis, Fitzpatrick, Cole & Giblin, LLP 500 Frank W. Burr Boulevard Glenpointe Centre West, 5th Floor Teaneck, New Jersey 07666 (201) 347-2107 (direct) (201) 928-0588 (fax) Email: [email protected]